Ellen Lund Sagen
- Senior engineer; BSc
- +47 23 07 27 88
Publications 2021
NEIL3-deficiency increases gut permeability and contributes to a pro-atherogenic metabolic phenotype
Sci Rep, 11 (1), 19749
DOI 10.1038/s41598-021-98820-0
Endonuclease V Regulates Atherosclerosis Through C-C Motif Chemokine Ligand 2-Mediated Monocyte Infiltration
J. Am. Heart Assoc., 10 (14), e020656
DOI 10.1161/JAHA.120.020656
DNA glycosylase Neil3 regulates vascular smooth muscle cell biology during atherosclerosis development
Atherosclerosis, 324, 123-132
DOI 10.1016/j.atherosclerosis.2021.02.023
Publications 2020
Soluble Markers of Interleukin 1 Activation as Predictors of First-Time Myocardial Infarction in HIV-Infected Individuals
J. Infect. Dis., 221 (4), 506-509
DOI 10.1093/infdis/jiz253
Plasma levels of interleukin 27 in falciparum malaria is increased independently of co-infection with HIV: potential immune-regulatory role during malaria
BMC Infect. Dis., 20 (1), 65
DOI 10.1186/s12879-020-4783-8
Publications 2019
Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
EBioMedicine, 46, 264-273
DOI 10.1016/j.ebiom.2019.07.024
Neuromodulatory Effect of NLRP3 and ASC in Neonatal Hypoxic Ischemic Encephalopathy
Neonatology, 115 (4), 355-362
DOI 10.1159/000497200
Publications 2018
Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack
J. Am. Heart Assoc., 7 (2), e006479
DOI 10.1161/JAHA.117.006479
Publications 2017
Tissue factor pathway inhibitor attenuates ER stress-induced inflammation in human M2-polarized macrophages
Biochem. Biophys. Res. Commun., 491 (2), 442-448
DOI 10.1016/j.bbrc.2017.07.070
Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
PLoS One, 12 (11), e0188387
DOI 10.1371/journal.pone.0188387
Publications 2015
Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
Atherosclerosis, 243 (1), 204-210
DOI 10.1016/j.atherosclerosis.2015.09.010
Publications 2014
Matrix Metalloproteinase 7 Is Associated with Symptomatic Lesions and Adverse Events in Patients with Carotid Atherosclerosis
PLoS One, 9 (1), e84935
DOI 10.1371/journal.pone.0084935
Interleukin-10 increases reverse cholesterol transport in macrophages through its bidirectional interaction with liver X receptor alpha
Biochem. Biophys. Res. Commun., 450 (4), 1525-1530
DOI 10.1016/j.bbrc.2014.07.036
Activated platelets promote increased monocyte expression of CXCR5 through prostaglandin E2-related mechanisms and enhance the anti-inflammatory effects of CXCL13
Atherosclerosis, 234 (2), 352-359
DOI 10.1016/j.atherosclerosis.2014.03.021
Publications 2012
Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosis
BMC Infect. Dis., 12, 144
DOI 10.1186/1471-2334-12-144
Increased levels of the homeostatic chemokine CXCL13 in human atherosclerosis - Potential role in plaque stabilization
Atherosclerosis, 224 (1), 266-273
DOI 10.1016/j.atherosclerosis.2012.06.071
Publications 2008
Soluble CD36 in Plasma Is Increased in Patients With Symptomatic Atherosclerotic Carotid Plaques and Is Related to Plaque Instability
Stroke, 39 (11), 3092-3095
DOI 10.1161/STROKEAHA.108.517128
Publications 2007
Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease
Scand. J. Clin. Lab. Invest., 67 (6), 604-611
DOI 10.1080/00365510701283878
Publications 2006
Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor
J. Mol. Cell. Cardiol., 41 (4), 689-697
DOI 10.1016/j.yjmcc.2006.07.009